MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Regulation in speech motor control in ET patients treated with DBS: Kinematics of the lingual and the labial systems

    D. Muecke, A. Hermes, M.T. Barbe, T.B. Roettger, N. Henrik, J. Becker, M. Hartinger, I. Meister, V. Visser-Vandewalle, L. Timmermann, M. Grice (Cologne, Germany)

    Objective: We aim to quantify the effects of VIM-DBS on speech regulation mechanisms in patients with Essential Tremor (ET). Background: VIM-DBS is an effective treatment…
  • 2016 International Congress

    Substantia nigra α4β2 nicotinic cholinergic receptor expression correlates with tremor in Parkinson’s disease

    M. Muller, R. Albin, N. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between tremor and α4β2 nicotinic cholinergic receptor (nAChR) expression in brain regions associated with tremor in Parkinson's disease (PD), including…
  • 2016 International Congress

    Movement disorders are the common signs as the first neurological deficit in cases with spinocerebellar ataxia type 2 (SCA2)

    N. Miyaue, R. Ando, T. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, H. Takashima, M. Nomoto (Ehime, Toohn City, Japan)

    Objective: We studied neurological signs in cases with SCA2 for early diagnosis. Background: SCA2 is a classification of hereditary ataxia, however, patients with SCA2 have…
  • 2016 International Congress

    Can quantitative analysis of the “finger-to-nose test” discern between EOA and other conditions of coordination impairment?

    O.E. Martinez Manzanera, T. Lawerman, D.A. Sival, N. Maurits (Groningen, Netherlands)

    Objective: In Early Onset Ataxia (EOA), we investigated whether quantitative analysis employing motion sensors could provide reliable and discriminative outcomes. Background: Many pediatric conditions can…
  • 2016 International Congress

    Iron accumulation and volume loss in the extrapyramidal motor system in Friedreich ataxia: The IMAGE-FRDA study

    I. Harding, M. Delatycki, L. Corben, P. Raniga, M. Stagnitti, E. Storey, N. Georgiou-Karistianis, G. Egan (Melbourne, Australia)

    Objective: To examine whether iron dysregulation and neurodegeneration influences the motor system outside of the cerebellum in Friedreich ataxia (FRDA). Background: FRDA is an autosomal…
  • 2016 International Congress

    Chorea-acanthocytosis: The first described clinical case in Ukraine

    Y.O. Trufanov (Kyiv, Ukraine)

    Objective: The abstract provides a description of the clinical case of chorea-acanthocytosis diagnosed at the Department of Neurology No. 1 of the Kyiv Regional Clinical…
  • 2016 International Congress

    Early grey matter changes in structural covariance networks in Huntington’s disease

    E.M. Coppen, J. van der Grond, A. Hafkemeijer, S.A.R.B. Rombouts, R.A.C. Roos (Leiden, Netherlands)

    Objective: To identify network integrity changes in Huntington's disease (HD) using grey matter whole brain structural covariance networks and to examine relationships between anatomical networks…
  • 2016 International Congress

    Indirect comparison of tolerability of deutetrabenazine and tetrabenazine in the FIRST-HD and TETRA-HD trials

    D.O. Claassen, B. Carroll, L.M. De Boer, E. Wu, R. Ayyagari, S. Gandhi, D. Stamler (Nashville, TN, USA)

    Objective: To compare the tolerability of deutetrabenazine (DTB) and tetrabenazine (TBZ) as observed in the FIRST-HD (NCT01795859) and TETRA-HD (NCT00219804) trials for the treatment of…
  • 2016 International Congress

    Alternatives for reducing chorea in Huntington disease, a long-term trial (ARC-HD): Updated week 8 results for the switch cohort

    V. Sung, D. Stamler, D.O. Claassen (Birmingham, AL, USA)

    Objective: To evaluate the sustained safety and efficacy following overnight switch from tetrabenazine (TBZ) to deutetrabenazine in patients with chorea associated with Huntington disease (HD).…
  • 2016 International Congress

    The value of multi-slice computed tomography angiography in diagnosis of intracranial circulation in patients with vascular parkinsonism

    M. Ataniyazov, G. Rakhimbaeva, K. Ataniyazova (Tashkent, Uzbekistan)

    Objective: The purpose of research was to evaluate the results of multislice computed tomographic angiography (MSCTA) in patients with vascular parkinsonism (VP) with stenotic lesions…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley